Clinical trials
Completed Phase 4 Hyperkalemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Duke University | 1 |
| Maisonneuve-Rosemont Hospital | 1 |
| NYU Langone Health | 1 |
| Nantes University Hospital | 1 |
| National Heart Foundation of Bangladesh | 1 |
| NephroNet, Inc. | 1 |
| Oman Medical Speciality Board | 1 |
| Oslo University Hospital | 1 |
| Relypsa, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperkalemia | 13 |
| Renal Insufficiency, Chronic | 3 |
| Insulin Resistance | 2 |
| Kidney Failure, Chronic | 2 |
| Ascites | 1 |
| Fibrosis | 1 |
| Hypertension | 1 |
| Hypokalemia | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.